1. Leukemia Service and
2. Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;
3. Department of Medicine, Icahn School of Medicine, Mount Sinai St Luke’s and Mount Sinai West, New York, NY;
4. Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine and
5. Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI;
6. Department of Oncology, King Faisal Specialist Hospital Center and Research, Riyadh, Saudi Arabia;
7. Department of Medicine, Bone Marrow Transplant and Cell Therapy Program, Columbia University Irving Medical Center, New York, NY;
8. Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Switzerland;
9. Division of Hematology, Oncology and Stem Cell Transplant, Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL;
10. Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL;
11. Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL;
12. The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE;
13. The Ottawa Hospital Blood and Marrow Transplant Program, Ottawa ON, Canada;
14. Ottawa Hospital Research Institute, Ottawa, ON, Canada;
15. Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN;
16. Division of Hematology & Oncology, Department of Pediatrics in the College of Medicine, UF Health Shands Children's Hospital, Gainesville, FL;
17. Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, MA;
18. Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI;
19. Division of Cancer Medicine, Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX;
20. Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA;
21. Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, FL;
22. Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI) Clinical Genetics Branch, National Institutes of Health (NIH), Rockville, MD;
23. Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom;
24. Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, KS;
25. Section of Hematology, Department of Medicine, Yale University School of Medicine, Yale Comprehensive Cancer Center, Yale New Haven Hospital, New Haven, CT;
26. Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC;
27. Department of Internal Medicine, Mayo Clinic, Rochester, MN;
28. Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia;
29. Markey Cancer Center, University of Kentucky, Lexington, KY;
30. Experimental Transplantation and Immunology Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD;
31. UT Southwestern Medical Center, Blood and Marrow Transplant Program, Dallas, TX;
32. H Lee Moffitt Cancer Center and Research Institute, Tampa, FL;
33. Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY;
34. Department of Medicine, University Hospitals Case Medical Center and Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH;
35. Section of Hematology/Oncology, University of Chicago Medicine, Chicago, IL;
36. Division of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain;
37. Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, ON, Canada;
38. Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL;
39. Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden;
40. Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden;
41. Blood and Marrow Transplantation Program and
42. Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY;
43. Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC;
44. Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel;
45. Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN;
46. Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan;
47. Department of Bone Marrow Transplantation and Cellular Therapy, St Jude Children’s Research Hospital, Memphis, TN;
48. The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA;
49. Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL;
50. Department of Hematology and Oncology, Isala Clinic, Zwolle, The Netherlands;
51. National Heart Lung, and Blood Institute, NIH, Bethesda, MD;
52. Division of Medical Oncology, University of Washington, Seattle, WA;
53. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
54. Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, MN;
55. Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX;
56. Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN; and
57. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY